1. Home
  2. BHVN vs AUB Comparison

BHVN vs AUB Comparison

Compare BHVN & AUB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
    SELLHOLDBUYas of 3 hours ago
  • AUB
    SELLHOLDBUYas of 3 hours ago
  • Stock Information
  • Founded
  • BHVN 2013
  • AUB 1902
  • Country
  • BHVN United States
  • AUB United States
  • Employees
  • BHVN N/A
  • AUB N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • AUB Major Banks
  • Sector
  • BHVN Health Care
  • AUB Finance
  • Exchange
  • BHVN Nasdaq
  • AUB Nasdaq
  • Market Cap
  • BHVN 2.9B
  • AUB 2.8B
  • IPO Year
  • BHVN 2017
  • AUB N/A
  • Fundamental
  • Price
  • BHVN $23.55
  • AUB $30.32
  • Analyst Decision
  • BHVN Strong Buy
  • AUB Buy
  • Analyst Count
  • BHVN 14
  • AUB 5
  • Target Price
  • BHVN $63.15
  • AUB $42.80
  • AVG Volume (30 Days)
  • BHVN 1.2M
  • AUB 1.3M
  • Earning Date
  • BHVN 03-03-2025
  • AUB 04-24-2025
  • Dividend Yield
  • BHVN N/A
  • AUB 4.36%
  • EPS Growth
  • BHVN N/A
  • AUB N/A
  • EPS
  • BHVN N/A
  • AUB 2.24
  • Revenue
  • BHVN N/A
  • AUB $767,328,000.00
  • Revenue This Year
  • BHVN N/A
  • AUB $79.58
  • Revenue Next Year
  • BHVN $65.26
  • AUB $17.05
  • P/E Ratio
  • BHVN N/A
  • AUB $13.93
  • Revenue Growth
  • BHVN N/A
  • AUB 14.48
  • 52 Week Low
  • BHVN $21.47
  • AUB $29.89
  • 52 Week High
  • BHVN $55.72
  • AUB $44.54
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 26.93
  • AUB 30.24
  • Support Level
  • BHVN $21.47
  • AUB $29.89
  • Resistance Level
  • BHVN $31.18
  • AUB $33.27
  • Average True Range (ATR)
  • BHVN 1.72
  • AUB 0.81
  • MACD
  • BHVN -0.23
  • AUB -0.01
  • Stochastic Oscillator
  • BHVN 20.91
  • AUB 25.44

Stock Price Comparison Chart: BHVN vs AUB

BHVN
AUB
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April051015202530354045505560BHVN VS AUB

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About AUB Atlantic Union Bankshares Corporation

Atlantic Union Bankshares Corp is a financial holding company and a bank holding company. Through its community bank subsidiary, the company provides financial services, including banking, trust, and wealth management. The bank is a full-service community bank offering consumers and businesses a wide range of banking and related financial services, including checking, savings, certificates of deposit, and other depository services, as well as loans for commercial, industrial, residential mortgage, and consumer purposes. The company operates through two reportable operating segments: Wholesale Banking and Consumer Banking, with corporate support functions such as corporate treasury and others included in Corporate Other. It derives maximum revenue from Wholesale Banking.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use